Загрузка...
Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations
BACKGROUND: Refractory blood loss is a common problem in surgeries for acute type A aortic dissections. Significant evidence has supported the benefit of using recombinant activated factor VII (rFVIIa) to control of intractable bleeding in patients after cardiac surgery. In this prospective clinical...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4156631/ https://ncbi.nlm.nih.gov/pubmed/25179738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13019-014-0156-y |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|